Found 159 matching trials
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
N/AThis is a single-center, bidirectional (retrospective and prospective) regi...
Location
Peking University Cancer Hospital
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer
PHASE2The goal of this clinical trial is to learn whether new adjuvant radiothera...
Location
Multiple Locations
Effect of Virtual Reality on Preoperative Anxiety
NAThe aim of this study was to determine the effect of virtual reality (VR) o...
Location
Mersin University Hospital
Elective vs Therapeutic Neck Dissection in Treatment of Early Node Negative Squamous Carcinoma of Oral Cavity
NACervical nodal metastasis is the single most important prognostic factor in...
Location
Tata Memorial Hospital
Organ Preservation in Locally Advanced Rectal Cancer
NAPRONAR trial aims to assess if treatment with organ preservation in stage I...
Location
Hospital General Universitario de Elche
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
PHASE3RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Location
Universitaetsklinik fuer Innere Medizin I
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)
PHASE2The goal of this clinical trial is to evaluate whether a total neoadjuvant ...
Location
The Sixth Affiliated Hospital of Sun Yat-sen University
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer
PHASE3The goal of this clinical trial is to find out if adding a PD-1 antibody (s...
Location
Sun Yat-Sen University Cancer Center
Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer
NAThe goal of this one-arm clinical trial is to implement and study the oncol...
Location
East Tallinn Central Hospital
Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma
PHASE2Hepatocellular carcinoma (HCC) accounts for more than 90% of primary liver ...
Location
Sun Yat-Sen University Cancer Center